Arkolith/Insider Trading/OMIC/Form 4

Spaventa Andrew

Chief Executive Officer, DirectorSingular Genomics Systems, Inc. (OMIC) · full profile →Form 4 · filed Feb 25, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
9
4 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 21, 2025Disposed to issuer(D)138K——0
Feb 21, 2025Disposed to issuer(D)5K——138K
Feb 21, 2025Disposed to issuer(D)325——0
Feb 21, 2025Disposed to issuer(D)85——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 21, 2025Disposed to issuer(D)43K$1.10$47K0
Feb 21, 2025Disposed to issuer(D)4K$20.00$87K0
Feb 21, 2025Disposed to issuer(D)16K—$00
Feb 21, 2025Disposed to issuer(D)23K$20.00$457K0
Feb 21, 2025Disposed to issuer(D)33K—$00

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-027112) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML